Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 121 AL 135

Novel protein acylations in Alzheimer's disease: Molecular, mechanisms, biological significance, and diagnostic and therapeutic potentials

Yang Y, Yu Z, Gao R, Zhang Y, Zhang Z, Zhong X, Jiao L, Du K, Wu Y, Wei M, Liu M.

J Adv Res. 2026 Aug;86:767-784. doi: 10.1016/j.jare.2025.11.050. Epub 2025 Nov 25.

Brain PET in the era of anti-amyloid-β antibody therapy for Alzheimer disease

Ishii K.

Jpn J Radiol. 2026 Aug;44(8):1356-1367. doi: 10.1007/s11604-026-01998-4. Epub 2026 Apr 25.

Long-term effects of multisession gamma transcranial alternating current stimulation in Alzheimer's disease

Cantoni V, Grassi M, Premi E, Cupidi C, Zummo E, Cotelli MS, Benussi A, Borroni B.

J Alzheimers Dis. 2026 Aug;112(4):1759-1763. doi: 10.1177/13872877261461248. Epub 2026 Jun 30.

The Promise and Peril of Alzheimer Disease Prevention

Grill JD, Graff-Radford J.

Neurology. 2026 Aug 11;107(3):e218348. doi: 10.1212/WNL.0000000000218348. Epub 2026 Jul 17.

Multi-case review of posterior cortical atrophy in a neuropsychology clinic

Dewhurst HE, Jorda L, Aranda A, Chunduri B, Lopez OL, Patira R, Gogniat MA.

Neurocase. 2026 Aug;32(4):141-151. doi: 10.1080/13554794.2026.2710636. Epub 2026 Jul 30.

Agentic AI for scaling diagnosis and care in neurodegenerative disease

Breithaupt AG, Weiner M, Tang A, Possin KL, Sirota M, Lah J, Levey AI, Van Hentenryck P, Zandehshahvar R, Gorno-Tempini ML, Giorgio J, Wang J, Rauschecker AM, Rosen HJ, Nosheny RL, Miller BL, Pinheiro-Chagas P.

Nat Aging. 2026 Aug;6(8):1565-1579. doi: 10.1038/s43587-026-01186-z. Epub 2026 Jul 30.

Impact of Narrative Nursing and Cognitive Behavioral Rehabilitation on Cognitive Function and Anxiety in Patients With Alzheimer's Disease

Shao R, Li W, Su H, Zhou S, Lan M, Li D.

Geriatr Gerontol Int. 2026 Aug;26(8):e70719. doi: 10.1111/ggi.70719.

Considerations for using amyloid-targeting therapies for the treatment of early symptomatic Alzheimer's disease

Budson AE, Ljubenkov PA, Ritter A, Leahy C, Ramanan VK, Brosch J, Burke A, Matthews BR.

Front Neurol. 2026 Aug 10;17:1863897. doi: 10.3389/fneur.2026.1863897. eCollection 2026.

Emotion recognition deficits in Alzheimer's disease: A meta-analysis

Zamora A, Balboa-Bandeira Y, Peña J, Ojeda N.

Neurosci Biobehav Rev. 2026 Aug;187:106745. doi: 10.1016/j.neubiorev.2026.106745. Epub 2026 May 13.

White matter abnormalities in Alzheimer's disease: Implications for pathophysiology, diagnosis, and treatment

Chen Z, Yang K, Lin F, Tang W, Shi Y, Zhou S, Liu J, You Y.

Ageing Res Rev. 2026 Oct;121:103229. doi: 10.1016/j.arr.2026.103229. Epub 2026 Jul 5.

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal

Tonietto M, Silvestri E, Belder CRS, Barkhof F, Fox NC, Smith J, Klein G.

Alzheimers Dement. 2026 Aug;22(8):e71749. doi: 10.1002/alz.71749.

Four-year evolution of the retinal microvasculature in an APOE ε4/ε4 cognitively normal individual

Patel H, Corpuz E, Liu AJ, Whitson H, Grewal D, Fekrat S.

BMJ Case Rep. 2026 Aug 19;19(8):e274211. doi: 10.1136/bcr-2026-274211.

Longitudinal effects of physical activity on sleep in association with hippocampal-amygdala subfield structure and functional connectivity in Alzheimer's disease

Dadsena R, Costa AS, David S, Haberl L, Schulz JB, Reetz K, Haeger A.

Alzheimers Dement. 2026 Aug;22(8):e71651. doi: 10.1002/alz.71651.

APOE-guided lecanemab dosing dissociates ARIA-E from ARIA-H: The K-ROAD study

Kang H, Jang H, Ahn J, Na DL, Lee JH, Kim EJ, Chun MY, Cho SH, Kim BC, Kim SE, Sohn G, Yun J, Lee JS, Park KC, Park HK, Kim YJ, Lee K, Yim S, Kim S, Kim JP, Kim HJ, Lim JS, Seo SW.

Alzheimers Dement. 2026 Aug;22(8):e71765. doi: 10.1002/alz.71765.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias